Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $145

Futu NewsOct 21 20:31 · Ratings

Glaukos IDose: Transforming Glaucoma Treatment With Promising Growth Potential

TipRanksOct 21 20:16

GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa

Zacks Oct 17 22:35

Glaukos Eyes FDA Approval for Ocular Therapy After Phase III Win

Yahoo FinanceOct 17 22:06

Stifel Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $145

Futu NewsOct 17 20:31 · Ratings

Stifel Nicolaus Issues a Buy Rating on Glaukos (GKOS)

TipRanksOct 17 20:05 · Ratings